Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
DOI: 10.1056/nejmoa2510703Author: Lana A. Castellucci et al.Published: 2026-3-12

Forum › Forums › Available Download: › DOI › Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

DOI: 10.1056/nejmoa2510703Author: Lana A. Castellucci et al.Published: 2026-3-12

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 13, 2026 at 5:45 pm #1030
    eugenedithermanEugeneDitherman
    Participant

    Title: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
    Journal: New England Journal of Medicine
    Authors: Lana A. Castellucci, Vivien M. Chen, Michael J. Kovacs, Alejandro Lazo-Langner, Peter Greenstreet, Susan Kahn, Benoit Côté, Sam Schulman, Kerstin de Wit, James Douketis, Deepa Suryanarayan, Tony Wan, Erik Yeo, Genevieve Le Templier, Huyen A. Tran, Abbey Willcox, Helen J. Crowther, Ritam Prasad, Sudeep Shivakumar, Etimbuk Umana, Fionnuala Ni Ainle, Tobias Tritschler, Stefano Barco, Jean-Philippe Galanaud, Marc Blondon, Lisa Baumann Kreuziger, Susan Solymoss, Clive Kearon, Erin Thomas, Tim Ramsay, Gregoire Le Gal, Marc Rodger
    Date: 2026-3-12
    DOI: 10.1056/nejmoa2510703
    Source: Massachusetts Medical Society
    Source URL: https://doi.org/10.1056/nejmoa2510703

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.